Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04100967 · ClinicalTrials.gov registry record

Examining the Longitudinal Relationship Between Sleep and Weight Gain in College Students

A clinical trial of Healthy and Overweight, sponsored by Oakland University.

Completed
Registry status
116
Enrollment target
1
Study location

NCT04100967: Completed study of Healthy and Overweight, sponsored by Oakland University.

NCT04100967 is a study of Healthy and Overweight that has completed, run by Oakland University. The registered enrollment target is 116 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04100967, a study of Healthy and Overweight, has completed, sponsored by Oakland University.

COMPLETED
Registry status
116 participants
Enrollment target
1
Study location

Study Summary

This two-year prospective, observational study examines the relationship between habitual short sleep and weight gain, as well as the association between habitual short sleep and behaviors that put people at risk of weight gain. Habitual short sleep is defined as sleeping \<6 hours per night on average. Participants will be healthy freshmen college students who are normal weight or overweight. Exclusion criteria include pregnancy, an inability to be ambulatory, currently taking a medication that could influence or interfere with sleep, or reporting a past/current neurological problem, past/current head injury, past/current sleep disorder, current mood, anxiety, or substance use disorder, current psychosis, or current suicidal ideation/plans. Recruitment will be during new student orientations that occur prior to fall semester. Eligibility will be determined using a screening interview, the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure - Adult, and DSM-5 Self-Rated Level 2 measures. Eligible participants will be assessed at baseline (time 1), and 8, 16, and 24 months after Time 1. Sleep, physical activity, food/beverages, substance use, and technology use will be collected daily during each eight day recording period. Sleep will be measured with a sleep monitor, activity will be assessed using an accelerometer, food/beverages will be obtained using the National Cancer Institute's Automated Self-Administered 24-hour Dietary Assessment Tool, and substance use and technology use will be measured via self-report. Participants will attend a session after each recording period to have weight and height measured, be scanned via Dual-energy x-ray absorptiometry (DXA), and complete a packet of questionnaires about demographics, health, sleep quality and beliefs, life events, food cravings, and physical development. It is hypothesized that participants will have different habitual sleep trajectories over time. It is also hypothesized that two particular sleep trajecto

Conditions Studied

Healthy Overweight

Study Locations (1)

Michigan

  • Oakland University - Rochester

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2017-06-14
Est. Completion 2021-06-30
Oakland University

9 total trials

What the finished NCT04100967 record still lists

NCT04100967 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT04100967 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04100967 about?

NCT04100967 is a clinical study titled "Examining the Longitudinal Relationship Between Sleep and Weight Gain in College Students". This two-year prospective, observational study examines the relationship between habitual short sleep and weight gain, as well as the association between habitual short sleep and behaviors that put people at risk of weight gain. Habitual short sleep is defined as sleeping \<6 hours per night on aver...

What is the current status of trial NCT04100967?

This trial is currently completed. The enrollment target is 116 participants. The study started on 2017-06-14. Estimated completion is 2021-06-30.

What conditions does trial NCT04100967 study?

This clinical trial studies the following conditions: Healthy, Overweight.

Who is sponsoring clinical trial NCT04100967?

This trial is sponsored by Oakland University, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04100967 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04100967's enrollment target sits among peer trials

116 198th of 1090 higher than 892 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04100967, the US trial registry maintained by the National Library of Medicine. NCT04100967 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.